US4464360A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Glycosphingalipids for inhibiting bacterial adherence
Assignee: Individual
•
Filing: 1981-05-08
•
Granted: 1984-08-07
•
Expires: 2001-05-08
Abstract
Abstract Pharmaceutical preparations containing globotetraosylceramide, globotriaozylceramide or globotetraos, and the use of said preparations or compounds for treatment, prophylaxis or diagnosis of bacterial infections in the urinary tract. The compounds have the ability to inhibit the adherence of bacteria to human urinary tract epithelial cells.
Inventors
- 👤 Hakon Leffler
- 👤 Catharina Svanborg Eden
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 03:15
CPC Classifications
C; C07; C07H; C07H3/00; C07H3/06; A; A61; A61K; A61K31/00; A61K31/70; Y; Y02; Y02A; Y02A50/00; Y02A50/30
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
48 words
A method of treating mammals suffering from infection due to bacteria adhering to the epithelial cells of the urinary tract comprising administering an amount of at least one of an active compound selected from the group consisting of globotetraosylceramide, globotriaoxylceramide and globotetraos effective to treat the bacterial infection.
Claim 2
Independent Claim
48 words
A method of treating mammals suffering from infection due to bacteria adhering to the epithelial cells of the urinary tract comprising administering an amount of at least one of an active compound selected from the group consisting of globotetraosylceramide, globotriaoxylceramide and globotetraos effective to treat the bacterial infection.
Claim 3
Independent Claim
62 words
A method of treating mammals suffering from infection due to bacteria adhering to the epithelial cells of the urinary tract comprising administering an amount of at least one of an active compound selected from the group consisting of globotetraosylceramide and globotriaosylceramide effective to treat the bacterial infection, together with lactosylceramide in proportions of 1:10 to 10:1 per weight of globotetraosylceramide or globotriaosylceramide.
Claim 4
Independent Claim
62 words
A method of treating mammals suffering from infection due to bacteria adhering to the epithelial cells of the urinary tract comprising administering an amount of at least one of an active compound selected from the group consisting of globotetraosylceramide and globotriaosylceramide effective to treat the bacterial infection, together with lactosylceramide in proportions of 1:10 to 10:1 per weight of globotetraosylceramide or globotriaosylceramide.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-08-07 | 1988-02-06 | 1988-08-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-08-07 | 1992-02-06 | 1992-08-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-08-07 | 1996-02-06 | 1996-08-07 | $7700.00 | Window Closed / Lapsed |